Active Pharmaceutical Ingredients (API)

Active Pharmaceutical Ingredients (API)
Product Description

Neopharma supplies NCEs, cGMP intermediates and KSMs to global innovators. It is equipped with flexible, versatile and advanced infrastructure, tailored to fit any complex chemistry molecules. Our API manufacturing facilities comply with all regulatory guidelines and requirements of current Good Manufacturing Practices (cGMP) and are successfully inspected/approved by health and regulatory agencies.

Certifications:
CGMP, WHO GMP, ISO 9001:2000; OHSAS and ISMS.


Planned certifications by: 
USFDA, EDQM, BfArM (Germany), TGA (Australia) and PMDA (Japan), AFSSAPS (France), ANVISA ( Brazil) and Cofepris ( Mexico).

Neopharma

  • AE
  • 2015
    On CPHI since
Specifications

Neopharma

  • AE
  • 2015
    On CPHI since

More Products from Neopharma (2)

  • Finished Dose Formulations

    Product Finished Dose Formulations

    6 state-of-the-art manufacturing sites globally. Our manufacturing operations are focused on producing generics, branded generics, specialty, over-the-counter (OTC) products, oncology.

    Major manufacturing partnerships with major global pharmaceutical companies such as Pfizer, Merck, GSK, Lagap, Abbot...
  • Research & Development

    Product Research & Development

    Manufacturing Research: 

    Over 200 products in 8 therapeutic categories available in various dosage forms including:
    • Controlled release tablets • Mouth dissolving tablets • Effervescent tablets • Bi-layered tablets • Enteric coated pellets • Dry syrups • SuspensionPellet in ca...